Your institution does not have access to this book on JSTOR. Try searching on JSTOR for other items related to this book. About the Book and Supporting Material 1 ...

In oncology drug development, biomarker-driven studies are pivotal, enabling the selection of patient populations most likely to benefit from specific therapeutic interventions. These studies have ...